PRESS RELEASE:
The Fourth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum Features Nation's Leading Pharmaceutical Sector Regulators and Compliance Professionals
  • Early Bird Registration Discount for National Pharma Congress Available Through this Friday, October 10
  • Sponsored by Pharmaceutical Compliance Forum
  • Nov. 12-14, 2003
  • Renaissance Marriott Hotel, Washington DC
  • www.PharmaCongress.com
PRESS RELEASE
Contact: Paul Tunnecliff
800-684-4549 phone
registration@hcconferences.com

WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICETM - OCTOBER 6, 2003: The Pharmaceutical Compliance Forum, the leading association of pharmaceutical industry compliance professionals, announced today the availability of a special Early Bird Registration Discount for its Fourth Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum, which will be held Nov. 12-14, 2003, in Washington DC. This special Early Bird Registration Discounted rate of $1,795 is available through this Friday, October 10, 2003. See www.PharmaCongress.com.

EARLY BIRD DISCOUNT AVAILABLE THROUGH OCTOBER 10:
  • The regular registration rate is $1,995.
  • The special Early Bird Registration Discounted rate of $1,795 is available through this Friday, October 10, 2003.
  • A special group discount registration rate of $1,495 is available for groups of 5 or more from the same organization.
  • For further registration info, go to the Congress website at http://www.pharmacongress.com/registration.html, call 800-684-4549, email: registration@hcconferences.com.
KEYNOTE SPEAKERS:

Thomas L. Abrams
Director, Division of Drug Marketing, Advertising & Communications, U.S. Food and Drug Administration, Rockville, MD

Arthur L. Caplan, Ph.D.
Director, Center for Bioethics, University of Pennsylvania, Fellow, American Association for the Advancement of Science, the Hastings Center, the College of Physicians of Philadelphia, and the New York Academy of Medicine, Philadelphia, PA

Dara Corrigan
Acting Principal Deputy Inspector General, Office of Inspector General, Department of health and Human Services, Washington, DC

Raymond Gilmarti
Chairman, President and CEO, Merck & Co., Inc., Whitehouse Station, NJ

John Guthrie, Esq.
Director, Medicaid Fraud Control Unit, Office of Attorney General, Columbus, OH

Thomas B. Leary, Esq.
Commissioner, Federal Trade Commission, Washington, DC

Michael Loucks, Esq.
Chief of the Health Care Fraud Unit, Assistant U.S. Attorney, U.S. Attorney's Office for the District of Massachusetts, Boston, MA

Mark B. McClellan, MD, Ph.D.
Commissioner of Food and Drugs, Food and Drug Administration, Rockville, MD

Dennis M. Nally
Chairman and Senior Partner, PricewaterhouseCoopers LLP, New York, NY

Thomas Scully
Administrator, Center for Medicare and Medicaid Services, Department of Health and Human Services,Washington, DC

James Sheehan, Esq.
Chief of the Civil Division, Assistant U.S. Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA

Janet Woodcock, MD
Director, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD

CONGRESS CO-CHAIRS:

Douglas M. Lankler, Esq.
Senior Corporate Counsel, Deputy Compliance Officer, Pfizer Inc., New York, NY

Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC

Bert Weinstein, Esq.
Vice President and Assistant General Counsel, Merck & Co., Whitehouse Station, NJ

CO SPONSORED BY:
  • Association of Clinical Research Professionals
  • Food & Drug Law Institute
  • International Federation of Pharmaceutical
  • Manufacturers Associations
  • International Pharmaceutical Privacy Consortium
  • IRB Forum
  • Pharmacy & Therapeutics (P&T) Society
  • Society for Research Administration International
  • American Pharmaceutical Review
  • BNA's Pharmaceutical Law & Industry Report
  • BNA's Medical Research Law & Policy Report
  • CenterWatch Monthly Newsletter
  • Clinical Trials Advisor
  • Drug & Market Development Publications
  • FDA News
  • Genaissance Health Care Partners
  • Harvard Health Policy Review
  • Health Affairs
  • Human Research Report
  • JobWatch Clinical Research Careers
  • Monitor
  • Pharma Marketing Network
  • Pharma Marketing News
  • Pharma Privacy Watch
SPONSOR: THE PHARMACEUTICAL COMPLIANCE FORUM:

The Congress is sponsored by the Pharmaceutical Compliance Forum (PCF). PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry, to promote effective corporate compliance programs. The organization is open to others in the industry, and has more than doubled its membership since it was founded. The members meet twice a year, for 1-2 days, focusing on open and informal sharing of compliance information, best practices and current developments in the field.

FEATURED FACULTY:

Joan Antokol
Chief Privacy Officer, Novartis, East Hanover, NJ

Alexis Leslie Barbieri, Esq.
Deputy Attorney General, Office of Attorney General, Harrisburg, PA

Tom Behan
Compliance Director, AstraZeneca, Wilmington, DE

John Bentivoglio, Esq.
Partner, Arnold and Porter, Former Special Counsel for Healthcare Fraud, Chief Privacy Officer, United States Department of Justice, Washington, DC

Raymond A. Bonner, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC

Mary Devlin Capizzi, Esq.
Partner, Gardner Carton & Douglas, Washington, DC

Heidi Chen, Esq.
Senior Corporate Counsel, Pfizer Inc., New York, NY

John Clay
Senior Adviser, E-Business, North American Commercial Operations, Aventis Pharmaceuticals, Bridgewater, NJ

Eve Costopoulos, Esq.
Staff Vice President, Compliance, Schering-Plough Corporation, Law Department, Kenilworth, NJ

Stanley W. Crosley, Esq.
Chief Privacy Officer, Eli Lilly and Company, Law Division, Indianapolis, IN

Teri Crouse, Esq.
Director of Compliance for Healthcare and Marketing, Eli Lilly and Company, Indianapolis, IN

Brian A. Dahl, Esq.
Counsel, Takeda Pharmaceuticals North America, Inc., Lincolnshire, IL

Sujata T. Dayal, Esq.
Counsel, Domestic Legal Operations, Abbott Laboratories, Abbott Park, IL

Anthony L. Farino
Partner, PricewaterhouseCoopers, Chicago, IL

William T. Fitzgerald, Esq.
Director, Global Compliance, Alcon Laboratories, Inc., Fort Worth, TX

Allison J. Gassaro Esq.
Senior Attorney, NA Legal, Aventis Pharmaceuticals, Bridgewater, NJ

Gary Giampetruzzi, Esq.
Compliance Counsel, Pfizer Inc., New York, NY

Robert G. Homchick, Esq.
Partner and Chair, Health Law Group, Davis Wright Tremaine, Seattle, WA

Peter Barton Hutt, Esq,
Partner, Covington & Burling, Former Chief Counsel, Food and Drug Administration, Washington, DC

Oliver Johnson, II
Chief Privacy Officer, Merck & Co., Whitehouse Station, NJ

Paul E. Kalb, MD, JD
Partner, Sidley Austin Brown & Wood, Washington, DC

Mark Allen Kleiman, Esq.
Partner, Law Offices of Mark Allen Kleiman, Los Angeles, CA

Kathleen A. Knight, Esq.
Vice President, Deputy General Counsel and Assistant Secretary, Alcon Laboratories, Inc., Fort Worth, TX

Richard P. Kusserow
President, Strategic Management Systems, Inc., Former Inspector General, Department of Health & Human Services, Washington, DC

Arthur N. Levine, Esq.
Partner, Arnold & Porter, Former Deputy Chief Counsel for Litigation, Food and Drug Administration, Washington, DC

Robert S. Litt, Esq.
Partner, Arnold & Porter, Former Principal Associate Deputy Attorney General, United States Department of Justice, Washington, DC

Justin McCarthy Esq.
Assistant General Counsel, Global Research and Development, Pfizer Inc., New London, CT

Stephen Meagher, Esq.
Partner, Phillips & Cohen, San Francisco, CA

Ed Miller, Esq.
Boehringer Ingelheim Pharmaceuticals

David Moskowitz, MBA, R.PH
Senior Vice President and Healthcare Senior Analyst, Friedman, Billings, Ramsey Group, Inc., Washington, DC

Edwin D. Rauzi, Esq.
Partner, Davis Wright Tremaine, Seattle, WA

Janet Rehnquist, Esq.
Partner, Venable LLP, Former Inspector General, Department of Health & Human Services, Washington, DC

Pat Roche
Partner, PricewaterhouseCoopers, Florham Park, NJ

Michele Russell-Einhorn, Esq.
Director, Clinical Research Consulting Team, PricewaterhouseCoopers, Former Director of Regulatory Affairs, Office for Human Research Protection, Washington, DC

Brenton L. Saunders, JD, MBA
Partner, PricewaterhouseCoopers, Past President, Health Care Compliance Association, Founder and Chair-elect, International Association of Privacy Officers, Florham Park, NJ

Catherine A. Sazdanoff
Divisional Vice President, Ethics and Compliance, Abbott Laboratories, Abbott Park, IL

Dalton Smart
Director, International Compliance, Schering-Plough Corporation, Kenilworth, NJ

Jonathan A. Smollen
Chief Privacy Officer, Wyeth Pharmaceuticals, St. Davids, PA

Steve Sokolow
Executive Director, Litigation, Novartis Pharmaceuticals Corporation, East Hanover, NJ

Ian Spatz
Vice President, Public Policy, Merck & Co., Inc., Washington, DC

Bert Spilker, PhD, MD, FCP, FFPM
President, Bert Spilker & Associates, Clinical Professor, Pharmacy Practice, University of Minnesota, Former Senior Vice President of Scientific and Regulatory Affairs, PhRMA, Bethesda, MD

Jane Stratton, Esq.
Vice President Associate General Counsel, And Chief Compliance Officer, Chiron Corporation, Emeryville, CA

Michael P. Swiatocha
Director, PricewaterhouseCoopers, Florham Park, NJ

Paul A. Sundberg Esq.
Staff Counsel, Commercial Legal Operations, Takeda Pharmaceuticals North America, Inc., Lincolnshire, IL

The Honorable Tommy Thompson (Invited)
Secretary, Department of Health and Human Services, Washington, DC

L. Stephan Vincze, Esq.
Ethics & Compliance Officer, TAP Pharmaceuticals, Lake Forest, IL

Caroline H. West, Esq.
Vice President, Global Legal Compliance, Legal Compliance Group, Aventis Pharmaceuticals, Bridgewater, NJ

EXHIBIT & SPONSORSHIP INFORMATION:

For sponsorship and exhibit information review the Promotional Opportunities pages on the Congress website: http://www.PharmaCongress.com or contact:

REGISTRATION INFORMATION:

For further registration info, go to the Congress website at http://www.pharmacongress.com/registration.html, call 800-684-4549, email: registration@hcconferences.com, or write:
    Pharma Congress Office
    7790 Barberry Ave.
    Yucca Valley, CA USA 92284
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

Please email your request to: webmaster@PharmaCongress.com.